Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 2.24% vs 22.66% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -18.77% vs 46.23% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 29.81% vs 28.25% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is -21.16% vs 66.00% in Mar 2024
Compare Profit and Loss Results of Anuh Pharma
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
661.00
407.00
254.00
62.41%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
661.00
407.00
254.00
62.41%
Expenditure (Ex Depriciation)
Stock Adjustments
-2.00
-2.00
0.00
0.00%
Raw Materials Consumed
501.00
197.00
304.00
154.31%
Power & Fuel Cost
12.00
11.00
1.00
9.09%
Employee Cost
23.00
57.00
-34.00
-59.65%
Operating Expenses
28.00
24.00
4.00
16.67%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
10.00
24.00
-14.00
-58.33%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
19.00
2.00
17.00
850.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
599.00
333.00
266.00
79.88%
Operating Profit (PBDIT) excl Other Income
61.00
74.00
-13.00
-17.57%
Other Income
9.00
20.00
-11.00
-55.00%
Operating Profit (PBDIT)
70.00
94.00
-24.00
-25.53%
Interest
1.00
10.00
-9.00
-90.00%
Profit before Depriciation and Tax
69.00
83.00
-14.00
-16.87%
Depreciation
8.00
12.00
-4.00
-33.33%
Profit Before Taxation & Exceptional Items
61.00
70.00
-9.00
-12.86%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
61.00
70.00
-9.00
-12.86%
Provision for Tax
13.00
23.00
-10.00
-43.48%
Profit After Tax
47.00
47.00
0.00
0.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
156.00
145.00
11.00
7.59%
Profit Available for appropriations
203.00
193.00
10.00
5.18%
Appropriations
203.00
193.00
10.00
5.18%
Equity Dividend (%)
30%
10%
20.00
Earnings Per Share
9.45
1.41
8.04
570.21%
Profit And Loss - Net Sales
Net Sales 661.51 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 2.24% vs 22.66% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 61.53 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -18.77% vs 46.23% in Mar 2024
Profit And Loss - Interest
Interest 1.24 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 29.81% vs 28.25% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 47.35 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -21.16% vs 66.00% in Mar 2024
